{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T19:10:10Z","timestamp":1751397010435,"version":"3.41.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172503"],"award-info":[{"award-number":["82172503"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302769"],"award-info":[{"award-number":["82302769"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-06748-6","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T18:42:11Z","timestamp":1751395331000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DDTC-Cu(I) inhibits human osteosarcoma cells growth by repressing MET\/PI3K\/AKT signaling pathway"],"prefix":"10.1038","volume":"15","author":[{"given":"Ruhao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongchun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaojian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengcui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochen","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"6748_CR1","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/cncr.24121","volume":"115","author":"L Mirabello","year":"2009","unstructured":"Mirabello, L., Troisi, R. J. & Savage, S. A. Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the surveillance, epidemiology, and end results program. Cancer 115, 1531\u20131543 (2009).","journal-title":"Cancer"},{"key":"6748_CR2","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ctrv.2013.11.006","volume":"40","author":"A Luetke","year":"2014","unstructured":"Luetke, A., Meyers, P. A., Lewis, I. & Juergens, H. Osteosarcoma treatment - where do we stand? A state of the art review. Cancer Treat. Rev. 40, 523\u2013532 (2014).","journal-title":"Cancer Treat. Rev."},{"key":"6748_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40744-016-0046-y","volume":"3","author":"RA Durfee","year":"2016","unstructured":"Durfee, R. A., Mohammed, M. & Luu, H. H. Review of osteosarcoma and current management. Rheumatol. Ther. 3, 221\u2013243 (2016).","journal-title":"Rheumatol. Ther."},{"key":"6748_CR4","first-page":"705","volume":"8","author":"DS Geller","year":"2010","unstructured":"Geller, D. S., Gorlick, R. & Osteosarcoma A review of diagnosis, management, and treatment strategies. Clin. Adv. Hematol. Oncol. 8, 705\u2013718 (2010).","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"6748_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nature25016","volume":"552","author":"Z Skrott","year":"2017","unstructured":"Skrott, Z. et al. Alcohol-abuse drug disulfiram targets cancer via P97 segregase adaptor Npl4. Nature 552, 194\u2013199 (2017).","journal-title":"Nature"},{"key":"6748_CR6","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.drudis.2020.04.003","volume":"25","author":"H Li","year":"2020","unstructured":"Li, H. et al. The combination of disulfiram and copper for cancer treatment. Drug Discov Today  25, 1099\u20131108 (2020).","journal-title":"Drug Discov Today"},{"key":"6748_CR7","doi-asserted-by":"crossref","unstructured":"Mandell, J. B. et al. Aldh1a1 gene expression and cellular copper levels between low and highly metastatic osteosarcoma provide a case for novel repurposing with disulfiram and copper. Sarcoma. 1\u201312 (2022).","DOI":"10.1155\/2022\/7157507"},{"key":"6748_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/jb\/mvab045","volume":"170","author":"W Guo","year":"2021","unstructured":"Guo, W. et al. The disulfiram\/copper complex induces apoptosis and inhibits tumour growth in human osteosarcoma by activating the ros\/jnk signalling pathway. J. Biochem. 170, 275\u2013287 (2021).","journal-title":"J. Biochem."},{"key":"6748_CR9","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s00424-020-02412-2","volume":"472","author":"J Chen","year":"2020","unstructured":"Chen, J. et al. The molecular mechanisms of copper metabolism and its roles in human diseases. Pflugers Arch. 472, 1415\u20131429 (2020).","journal-title":"Pflugers Arch."},{"key":"6748_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.taap.2013.09.009","volume":"273","author":"J Han","year":"2013","unstructured":"Han, J. et al. A binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenografts. Toxicol. Appl. Pharmacol. 273, 477\u2013483 (2013).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"6748_CR11","doi-asserted-by":"publisher","first-page":"131155","DOI":"10.1016\/j.cej.2021.131155","volume":"428","author":"G Zhang","year":"2022","unstructured":"Zhang, G. et al. A multifunctional antibacterial coating on bone implants for osteosarcoma therapy and enhanced osteointegration. Chem. Eng. J. 428, 131155 (2022).","journal-title":"Chem. Eng. J."},{"key":"6748_CR12","doi-asserted-by":"publisher","first-page":"620295","DOI":"10.3389\/fonc.2021.620295","volume":"11","author":"C Chen","year":"2021","unstructured":"Chen, C. et al. Mir-135a reduces osteosarcoma pulmonary metastasis by targeting both Bmi1 and Klf4. Front. Oncol. 11, 620295 (2021).","journal-title":"Front. Oncol."},{"key":"6748_CR13","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/1873-3468.13387","volume":"593","author":"CL Chen","year":"2019","unstructured":"Chen, C. L. et al. Mir-134 inhibits osteosarcoma cell invasion and metastasis through targeting Mmp1 and Mmp3 in vitro and in vivo. Febs Lett. 593, 1089\u20131101 (2019).","journal-title":"Febs Lett."},{"key":"6748_CR14","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"DSN Percie","year":"2020","unstructured":"Percie, D. S. N. et al. The arrive guidelines 2.0: Updated guidelines for reporting animal research. Plos Biol. 18, e3000410 (2020).","journal-title":"Plos Biol."},{"key":"6748_CR15","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nrc3838","volume":"14","author":"M Kansara","year":"2014","unstructured":"Kansara, M., Teng, M. W., Smyth, M. J. & Thomas, D. M. Translational biology of osteosarcoma. Nat. Rev. Cancer  14, 722\u2013735 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"6748_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejca.2017.09.036","volume":"88","author":"N Gaspar","year":"2018","unstructured":"Gaspar, N. et al. Results of methotrexate-etoposide-ifosfamide based regimen (M-Ei) in osteosarcoma patients included in the French Os2006\/Sarcome-09 study. Eur. J. Cancer. 88, 57\u201366 (2018).","journal-title":"Eur. J. Cancer"},{"key":"6748_CR17","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. Kegg: Biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"6748_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M., Goto, S. & Kegg Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"6748_CR19","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"6748_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cca.2021.12.017","volume":"525","author":"X Yang","year":"2022","unstructured":"Yang, X., Liao, H. Y. & Zhang, H. H. Roles of met in human cancer. Clin. Chim. Acta  525, 69\u201383 (2022).","journal-title":"Clin. Chim. Acta"},{"key":"6748_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.yexcr.2017.04.027","volume":"357","author":"XP Yang","year":"2017","unstructured":"Yang, X. P. et al. Pancreatic stellate cells increase pancreatic cancer cells invasion through the hepatocyte growth factor \/C-Met\/survivin regulated by P53\/P21. Exp. Cell. Res. 357, 79\u201387 (2017).","journal-title":"Exp. Cell. Res."},{"key":"6748_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.abb.2012.07.003","volume":"526","author":"K Wang","year":"2012","unstructured":"Wang, K., Zhuang, Y., Liu, C. & Li, Y. Inhibition of C-Met activation sensitizes osteosarcoma cells to cisplatin via suppression of the Pi3K-Akt signaling. Arch. Biochem. Biophys. 526, 38\u201343 (2012).","journal-title":"Arch. Biochem. Biophys."},{"key":"6748_CR23","doi-asserted-by":"publisher","first-page":"454","DOI":"10.2741\/4114","volume":"18","author":"L Goetsch","year":"2013","unstructured":"Goetsch, L., Caussanel, V. & Corvaia, N. Biological significance and targeting of C-Met tyrosine kinase receptor in cancer. Front. Biosci. 18, 454\u2013473 (2013).","journal-title":"Front. Biosci."},{"key":"6748_CR24","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41571-020-0377-z","volume":"17","author":"R Guo","year":"2020","unstructured":"Guo, R. et al. Met-dependent solid tumours\u2014molecular diagnosis and targeted therapy. Nat. Rev. Clin. Oncol. 17, 569\u2013587 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"6748_CR25","doi-asserted-by":"publisher","first-page":"118925","DOI":"10.1016\/j.lfs.2020.118925","volume":"268","author":"Q Wang","year":"2021","unstructured":"Wang, Q. et al. Mir-485-3P regulated by Malat1 inhibits osteosarcoma Glycolysis and metastasis by directly suppressing C-Met and Akt3\/Mtor signalling. Life Sci. 268, 118925 (2021).","journal-title":"Life Sci."},{"key":"6748_CR26","doi-asserted-by":"crossref","unstructured":"Wen, J. et al. Macc1 contributes to the development of osteosarcoma through regulation of the Hgf\/C-Met pathway and microtubule stability. Front Cell. Dev. Biol 8(2020).","DOI":"10.3389\/fcell.2020.00825"},{"key":"6748_CR27","doi-asserted-by":"crossref","unstructured":"Fioramonti, M. et al. Cabozantinib affects osteosarcoma growth through a direct effect on tumor cells and modifications in bone microenvironment. Sci Rep 8  (2018).","DOI":"10.1038\/s41598-018-22469-5"},{"key":"6748_CR28","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/jbmr.336","volume":"26","author":"ER Sampson","year":"2011","unstructured":"Sampson, E. R. et al. The orally bioavailable met inhibitor Pf-2341066 inhibits osteosarcoma growth and osteolysis\/matrix production in a xenograft model. J. Bone Min. Res. 26, 1283\u20131294 (2011).","journal-title":"J. Bone Min. Res."},{"key":"6748_CR29","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/cas.13900","volume":"110","author":"L Mei","year":"2018","unstructured":"Mei, L. et al. Norcantharidin inhibits proliferation and promotes apoptosis via C-Met\/Akt\/Mtor pathway in human osteosarcoma cells. Cancer Sci. 110, 582\u2013595 (2018).","journal-title":"Cancer Sci."},{"key":"6748_CR30","doi-asserted-by":"crossref","unstructured":"Liu, H., Deng, H., Zhao, Y., Li, C. & Liang, Y. Lncrna Xist\/Mir-34a Axis modulates the cell proliferation and tumor growth of thyroid Cancer through Met-Pi3K-Akt signaling. J Exp. Clin. Cancer Res 37 (2018).","DOI":"10.1186\/s13046-018-0950-9"},{"key":"6748_CR31","doi-asserted-by":"publisher","first-page":"118523","DOI":"10.1016\/j.lfs.2020.118523","volume":"263","author":"J Xu","year":"2020","unstructured":"Xu, J., Liu, S., Yang, X., Cao, S. & Zhou, Y. Paracrine Hgf promotes Emt and mediates the effects of Psc on chemoresistance by activating C-Met\/Pi3K\/Akt signaling in pancreatic cancer in vitro. Life Sci. 263, 118523 (2020).","journal-title":"Life Sci."},{"key":"6748_CR32","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.prp.2018.12.013","volume":"215","author":"Z Sun","year":"2019","unstructured":"Sun, Z., Jian, Y., Zhu, H. & Li, B. Lncrnapvt1 targets Mir-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating C-Met\/Pi3K\/Akt pathway. Pathol. - Res. Pract. 215, 555\u2013563 (2019).","journal-title":"Pathol. - Res. Pract."},{"key":"6748_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3349\/ymj.2019.60.2.163","volume":"60","author":"F Zhan","year":"2019","unstructured":"Zhan, F. et al. Microrna-206 reduces osteosarcoma cell malignancyin vitro by targeting the Pax3-met axis. Yonsei Med. J. 60, 163 (2019).","journal-title":"Yonsei Med. J."},{"key":"6748_CR34","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.pharmthera.2013.12.004","volume":"142","author":"JJ Polivka","year":"2014","unstructured":"Polivka, J. J. & Janku, F. Molecular targets for cancer therapy in the Pi3K\/Akt\/Mtor pathway. Pharmacol. Ther. 142, 164\u2013175 (2014).","journal-title":"Pharmacol. Ther."},{"key":"6748_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13046-021-02027-0","volume":"40","author":"B Yang","year":"2021","unstructured":"Yang, B. et al. Circular Rna circ_001422 promotes the progression and metastasis of osteosarcoma via the Mir-195-5P\/Fgf2\/Pi3K\/Akt axis. J. Exp. Clin. Cancer Res. 40, 235 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"6748_CR36","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.cca.2014.12.041","volume":"444","author":"J Zhang","year":"2015","unstructured":"Zhang, J., Yu, X. H., Yan, Y. G., Wang, C. & Wang, W. J. Pi3K\/Akt signaling in osteosarcoma. Clin. Chim. Acta. 444, 182\u2013192 (2015).","journal-title":"Clin. Chim. Acta"},{"key":"6748_CR37","doi-asserted-by":"publisher","first-page":"21090","DOI":"10.18632\/aging.203261","volume":"13","author":"K Zhang","year":"2021","unstructured":"Zhang, K., Wu, S., Wu, H., Liu, L. & Zhou, J. Effect of the Notch1-mediated Pi3K-Akt-Mtor pathway in human osteosarcoma. Aging (Albany Ny) 13, 21090\u201321101 (2021).","journal-title":"Aging (Albany Ny)"},{"key":"6748_CR38","doi-asserted-by":"crossref","unstructured":"Xiang, Y., Yang, Y., Liu, J. & Yang, X. Functional role of Microrna\/Pi3K\/Akt axis in osteosarcoma. Front Oncol. 13  (2023).","DOI":"10.3389\/fonc.2023.1219211"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06748-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06748-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06748-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T18:42:13Z","timestamp":1751395333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06748-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6748"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-06748-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"26 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21780"}}